| 000 | 01723 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250518061706.0 | ||
| 264 | 0 | _c20191209 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a2352-3026 | ||
| 024 | 7 |
_a10.1016/S2352-3026(19)30156-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAhmed, Asra | |
| 245 | 0 | 0 |
_aRuxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. _h[electronic resource] |
| 260 |
_bThe Lancet. Haematology _cDec 2019 |
||
| 300 |
_ae630-e637 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHistorically Controlled Study |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphohistiocytosis, Hemophagocytic _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeutrophils _xpathology |
| 650 | 0 | 4 | _aNitriles |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aPlatelet Count |
| 650 | 0 | 4 |
_aPyrazoles _xtherapeutic use |
| 650 | 0 | 4 | _aPyrimidines |
| 650 | 0 | 4 |
_aSplenomegaly _xblood |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aMerrill, Samuel A | |
| 700 | 1 | _aAlsawah, Fares | |
| 700 | 1 | _aBockenstedt, Paula | |
| 700 | 1 | _aCampagnaro, Erica | |
| 700 | 1 | _aDevata, Sumana | |
| 700 | 1 | _aGitlin, Scott D | |
| 700 | 1 | _aKaminski, Mark | |
| 700 | 1 | _aCusick, Alice | |
| 700 | 1 | _aPhillips, Tycel | |
| 700 | 1 | _aSood, Suman | |
| 700 | 1 | _aTalpaz, Moshe | |
| 700 | 1 | _aQuiery, Albert | |
| 700 | 1 | _aBoonstra, Philip S | |
| 700 | 1 | _aWilcox, Ryan A | |
| 773 | 0 |
_tThe Lancet. Haematology _gvol. 6 _gno. 12 _gp. e630-e637 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S2352-3026(19)30156-5 _zAvailable from publisher's website |
| 999 |
_c30128023 _d30128023 |
||